Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox's proprietary exosome technologyPartnership encompasses up to five rare disease targets, including...
Read More »Jazz Pharmaceuticals and Codiak BioSciences Announce $1B Strategic Collaboration to Research, Develop and Commercialize Engineered Exosomes
Collaboration strengthens Jazz portfolio with novel therapeutic approach that has potential to provide transformational benefit to subgroup of patients with modulations in well validated but previously...
Read More »Cancer Genetics, Inc. Announces Multiple Agreements & Collaborations to Develop Liquid Biopsy Programs with Leading Biopharma Companies
CGI has signed five agreements and contracts to develop focused, high-performance liquid biopsy tests for a broad range of solid tumors The liquid biopsy tests are focused on therapy monitoring & companion diagnostic development for a potential $20 billion market ...
Read More »